Genetic variants that lower LDL cholesterol are associated with proportionally lower cardiovascular disease risk
3 events · 1 assessment · 1 decision
Structured and assessed
First pass. Distinguished this associational/dose-response claim from the nearby causal MR claim [567d349b]: the association turns on the raw genetic epidemiology, whereas the causal reading additionally requires the no-pleiotropy MR assumptions, so they are distinct claims and this one is not a duplicate. Decomposed via a single natural line of support (no named argument needed), linking two existing verified claims: the magnitude estimate [777c4696] and cross-gene concordance [1b000ae7]. Confirmed proportionality directly in primary literature (Ference et al. 2×2 factorial NPC1L1/HMGCR study: 'log-linearly proportional to absolute exposure to lower LDL-C'). Assessed verified (0.93, credence 0.97): as an observed dose-response association it is more robust than the causal claim (already verified 0.92), and residual pleiotropy/canalization caveats bear on causal interpretation, not on the association. Importance 0.3 (contestation 0.15): consulted and foundational but the association itself is uncontested even among causal skeptics. Escalated a possible cross-claim link to the causal claim.
Assessed Verified
verdict confidence 0.93 · credence 0.97
Mendelian randomization studies consistently find that carriers of genetic variants associated with lifelong lower LDL cholesterol have lower risk of atherosclerotic cardiovascular disease, and the size of the risk reduction scales with the size of the LDL reduction. Pooled analyses estimate roughly 50-55% lower coronary heart disease risk for each 1 mmol/L genetically lower LDL, and variants in mechanistically distinct LDL genes give concordant per-unit estimates, with the relationship found to be approximately log-linear in cumulative LDL exposure. As an observed association with a dose-response form, the claim is not in serious dispute; the live debate in this area concerns how far the association can be read as the causal, lifelong effect of LDL, a stronger question that turns on additional Mendelian randomization assumptions rather than on the association itself.
Claim entered the graph